Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Toxys logo — Genetic, developmental, and investigative toxicology with Ne...

Toxys

Genetic, developmental, and investigative toxicology with New Approach Methodologies (NAMs)

Founded 2014 The Netherlands The Netherlands 41 employees Venture round Total: $2.05M Biotechnology, Health Care

General Information

Company Name Toxys
Founded Year 2014
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 41
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Toxys. To contact Toxys, visit toxys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 23, 2026

Toxys is participating as a speaker in a webinar scheduled for October 14th, 2026, discussing MNP uptake and cellular responses.

New Partnership Sep 22, 2026

Toxys announced an expanded collaboration with Mutagentech to offer SMM-seq through its contract research services.

Product Launch Sep 17, 2026

Toxys introduced its new MitoToxScreen assay, designed to improve the interpretation of mitochondrial toxicity responses for early compound screening and decision-making.

Regulatory Approval Sep 07, 2026

Toxys is celebrating the birth of the OECD Test guideline 446A for its ToxTracker assay.

Get alerts when Toxys shows new signals

About Toxys

Toxys develops and provides unique animal-free laboratory tests for safety assessments in the biotechnology and healthcare industries. It serves pharmaceutical, chemical, cosmetics, and food companies, and is based in The Netherlands.

Founded in 2014, Toxys specializes in genotoxicity, developmental toxicology, and mechanistic toxicity testing. Its main products include the ToxTracker® assay for identifying genotoxic compounds, ReproTracker® for detecting developmental toxicity, and the ToxProfiler™ assay for providing a broad toxicity profile. Toxys offers in vitro assays that deliver mode-of-action information essential for thorough chemical safety assessments and development of better medicines and products.

Taxonomy: toxicity testing, genotoxicity, developmental toxicology, mechanistic toxicity testing, compound risk assessment, in vitro assays, mode-of-action assessment, chemical safety assessment, animal-free testing, pharmaceutical testing, cosmetics testing, chemical testing, food safety, adverse outcome pathway, scientific expertise

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €2.00M 3
InnovationQuarter KIKK Capital
InnovationQuarter, KIKK Capital +1
12 Mar 2020
Grant €50.00K -
21 Sep 2016
Series A Undisclosed 2
InnovationQuarter
InnovationQuarter, Zeeuws Investerings Fonds
18 Feb 2016

Toxys Alternatives & Competitors

Toxys vs
Altis Biosystems
Altis Biosystems United States

Capturing the Complexity of the Human Gut

Series A
28 employees
Biotechnology, Health Care
Toxys vs
InvivoSciences® Inc.
InvivoSciences® Inc. United States

Discovery with Human touch

Non Equity Assistance
4 employees
Biotechnology, Health Care

FAQ About Toxys

Genetic, developmental, and investigative toxicology with New Approach Methodologies (NAMs)
Toxys was founded in 2014.
Toxys is headquartered in The Netherlands.
Toxys operates in Biotechnology and Health Care. Its work centres on toxicity testing, genotoxicity, developmental toxicology and mechanistic toxicity testing.
Toxys has approximately 41 employees.
Toxys has completed 3 funding rounds, raising a total of $2.05M. The latest funding stage is Venture round.
Top alternatives and competitors to Toxys include Altis Biosystems, InvivoSciences® Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Toxys and Altis Biosystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Toxys, https://bouncewatch.com/company/toxys, updated 29 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes